These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32553759)

  • 21. Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting.
    Sharma V; Shukla J; Suri V; Jena A; Mukerjee A; Mandavdhare HS; Bhalla A; Dutta U
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):465-466. PubMed ID: 33576700
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
    Caron B; Arondel Y; Reimund JM
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2637-2638. PubMed ID: 32522559
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry.
    Ungaro RC; Brenner EJ; Agrawal M; Zhang X; Kappelman MD; Colombel JF;
    Gastroenterology; 2022 Jan; 162(1):316-319.e5. PubMed ID: 34529987
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?
    Fan D; Gearry RB
    Aliment Pharmacol Ther; 2021 Jul; 54(2):208-209. PubMed ID: 34170535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
    Clough JN; Hill KL; Duff A; Sharma E; Ray S; Mawdsley JE; Anderson S; Irving PM; Samaan MA
    Inflamm Bowel Dis; 2020 Sep; 26(10):e125-e126. PubMed ID: 32592475
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update.
    Derks MEW; van Lierop LMA; Te Groen M; Kuijpers CCHJ; Nagtegaal ID; Hoentjen F
    Inflamm Bowel Dis; 2024 Jan; 30(1):146-149. PubMed ID: 37000678
    [No Abstract]   [Full Text] [Related]  

  • 27. Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Eltabbakh MM; Shamkh MAA; Bassuny AN; Abd Alaty WH; Sakr MA; Sherief AF
    Inflamm Bowel Dis; 2020 Oct; 26(11):1771-1778. PubMed ID: 32860060
    [No Abstract]   [Full Text] [Related]  

  • 28. The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable".
    Pugliese D; Papi C; Privitera G; Aratari A; Festa S; Armuzzi A
    Dig Liver Dis; 2020 Nov; 52(11):1238-1240. PubMed ID: 32601025
    [No Abstract]   [Full Text] [Related]  

  • 29. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
    McGregor CG; Adams A; Sadler R; Arancibia-Cárcamo CV; Palmer R; Ambrose T; Brain O; Walsh A; Klenerman P; Travis SP; Croft NM; Lindsay JO; Satsangi J
    Gut; 2021 Dec; 70(12):2398-2400. PubMed ID: 33579788
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Horrigan JM; Siegel CA; Tadros M
    Inflamm Bowel Dis; 2020 Oct; 26(11):e137. PubMed ID: 32737970
    [No Abstract]   [Full Text] [Related]  

  • 31. Implications of COVID-19 for patients with pre-existing digestive diseases.
    Mao R; Liang J; Shen J; Ghosh S; Zhu LR; Yang H; Wu KC; Chen MH; ;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):425-427. PubMed ID: 32171057
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dai C; Huang YH
    Dig Dis Sci; 2022 Jan; 67(1):348-349. PubMed ID: 33914215
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management].
    Stallmach A; Reuken PA; Grunert P; Teich N
    Z Gastroenterol; 2022 Dec; 60(12):1795-1801. PubMed ID: 35148564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?
    Malickova K; Kratka Z; Luxova S; Bortlik M; Lukas M
    Scand J Gastroenterol; 2020 Aug; 55(8):917-919. PubMed ID: 32663041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic.
    Vázquez García P; Fernández-Gordón Sánchez FM; Algara San Nicolás M; Yela San Bernardino C; Casis Herce B; Masedo González Á; Gómez Gómez GJ; Martínez Montiel MDP
    Rev Esp Enferm Dig; 2022 Jan; 114(1):58-59. PubMed ID: 34517711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic.
    Chen Y; Hu S; Wu H; Farraye FA; Bernstein CN; Zheng JJ; Kiran RP; Shen B
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):632-634. PubMed ID: 32411921
    [No Abstract]   [Full Text] [Related]  

  • 37. Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.
    Lees CW; Regueiro M; Mahadevan U;
    Gastroenterology; 2020 Sep; 159(3):805-808.e1. PubMed ID: 32474119
    [No Abstract]   [Full Text] [Related]  

  • 38. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 39. Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
    Allocca M; Fiorino G; Furfaro F; Gilardi D; Radice S; D'Amico F; Zilli A; Danese S
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1882-1883. PubMed ID: 32304737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 infection in patients with inflammatory bowel disease in the second-third wave and its comparison with data of first wave of pandemic.
    Algaba A; Guerra I; Castro S; Bermejo F
    Gastroenterol Hepatol; 2022; 45(7):572-573. PubMed ID: 34774924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.